Clariant refines specialty chemicals strategy, shares tracked against European peers
Published on 06/23/2026 at 15:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-23, 15:56.
Clariant (CH0012142631) remains a mid-cap specialty chemicals name in the Swiss SMI universe. Analysts currently focus on its margin profile and portfolio discipline versus European peers such as BASF and Evonik, based on the latest consensus data.
What analysts are modeling
On the SIX Swiss Exchange, Clariant shares are typically benchmarked against the broader European chemicals sector that includes BASF and Evonik. According to consolidated analyst data on MarketScreener, most houses expect moderate sales growth and a gradual margin improvement over the next two years, reflecting pricing power in key segments.MarketScreener consensus overview
Several banks, including UBS and Deutsche Bank, have recently reiterated neutral to positive views on European specialty chemicals, highlighting selective pricing strength and disciplined capital allocation. Their sector work often cites Clariant alongside Croda and Evonik as examples of companies focusing on higher-value niches rather than bulk chemicals.UBS sector commentary on European chemicals
Earnings calendar and guidance focus
Clariant lists its financial calendar and reporting dates on its investor relations site, including half-year and full-year results presentations in Zurich and conference calls with analysts and investors.Clariant financial calendar Market participants typically focus on the development of EBITDA margins, free cash flow and net debt, as well as any adjustments to medium-term guidance.
In recent reporting cycles, Clariant has aimed to demonstrate progress on its portfolio repositioning and cost efficiencies, which are central to its investment case in the specialty chemicals space. Investors also compare capex intensity and R&D spending with peers to gauge how the group balances innovation and returns.
All news and analysis on the Clariant shares
Key figures, ad-hoc announcements and background on Clariant’s position in the European specialty chemicals sector.
The business behind the stock
Clariant’s core operations center on specialty chemicals for care chemicals, catalysis and natural resources applications. The group supplies formulations and additives used in personal care, crop solutions, oil and mining services and industrial applications, focusing on higher-value, innovation-driven products rather than commodity chemicals.Clariant business unit overview
Where the stock trades today
The Clariant shares (CH0012142631) trade on the SIX Swiss Exchange; the latest verifiable price data from SIX shows the stock in Swiss francs, with intraday levels and market capitalization updated during regular Zurich trading hours.
Key data on the Clariant shares
- Company: Clariant AG
- ISIN: CH0012142631
- WKN: 895929
- Ticker: CLN
- Trading venue: SIX Swiss Exchange
- Price (as of 2026-06-23, 15:30): not live-verifiable CHF
- Market cap: not live-verifiable CHF (as of 2026-06-23)
- Sector / industry: Specialty Chemicals
- Index membership: SMI Mid / SPI
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
